Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau

被引:367
作者
Takashima, A
Murayama, M
Murayama, O
Kohno, T
Honda, T
Yasutake, K
Nihonmatsu, N
Mercken, M
Yamaguchi, H
Sugihara, S
Wolozin, B
机构
[1] RIKEN, Lab Alzheimers Dis, Brain Sci Inst, Wako, Saitama 35001, Japan
[2] Mitsubishi Kasei Inst Life Sci, Machida, Tokyo 194, Japan
[3] Mitsubishi Chem Corp, Yokohama Res Ctr, Yokohama, Kanagawa 194, Japan
[4] Gunma Univ, Sch Hlth Sci, Maebashi, Gumma 371, Japan
[5] Gunma Canc Ctr, Dept Pathol, Ota, Gunma 373, Japan
[6] Loyola Univ, Med Ctr, Dept Pharmacol, Maywood, IL 60153 USA
关键词
D O I
10.1073/pnas.95.16.9637
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Families bearing mutations in the presenilin 1 (PS1) gene develop Alzheimer's disease. Previous studies have shown that the Alzheimer-associated mutations in PS1 increase production of amyloid beta protein (A beta(1-42)) We now show that PS1 also regulates phosphorylation of the microtubule-associated protein tau. PS1 directly binds tau and a tau kinase, glycogen synthase kinase 3 beta (GSK-3 beta), Deletion studies show that both tau and GSK-3 beta bind to the same region of PS1, residues 250-298, whereas the binding domain on tau is the microtubule-binding repeat region. The ability of PSI to bring tau and GSK-3 beta into close proximity suggests that PSI may regulate the interaction of tau with GSK-3 beta. Mutations in PS1 that cause Alzheimer's disease increase the ability of PS1 to bind GSK-3 beta and, correspondingly, increase its tau-directed kinase activity. We propose that the increased association of GSK-3 beta with mutant PSI leads to increased phosphorylation of tau.
引用
收藏
页码:9637 / 9641
页数:5
相关论文
共 48 条
[41]   Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo [J].
Thinakaran, G ;
Borchelt, DR ;
Lee, MK ;
Slunt, HH ;
Spitzer, L ;
Kim, G ;
Ratovitsky, T ;
Davenport, F ;
Nordstedt, C ;
Seeger, M ;
Hardy, J ;
Levey, AI ;
Gandy, SE ;
Jenkins, NA ;
Copeland, NG ;
Price, DL ;
Sisodia, SS .
NEURON, 1996, 17 (01) :181-190
[42]  
Van Broeckhoven C, 1995, NAT GENET, V11, P230
[43]   Requirement of the familial Alzheimer's disease gene PS2 for apoptosis - Opposing effect of ALG-3 [J].
Vito, P ;
Wolozin, B ;
Ganjei, JK ;
Iwasaki, K ;
Lacana, E ;
DAdamio, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (49) :31025-31028
[44]   Participation of Presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation [J].
Wolozin, B ;
Iwasaki, K ;
Vito, P ;
Ganjei, JK ;
Lacana, E ;
Sunderland, T ;
Zhao, BY ;
Kusiak, JW ;
Wasco, V ;
DAdamio, L .
SCIENCE, 1996, 274 (5293) :1710-1713
[45]   Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease [J].
Xia, WM ;
Zhang, JM ;
Perez, R ;
Koo, EH ;
Selkoe, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8208-8213
[46]   Presenilin 1 immunostaining using well-characterized antibodies in human tissues [J].
Yamada, T ;
Takashima, A .
EXPERIMENTAL NEUROLOGY, 1997, 148 (01) :10-12
[47]   Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK)I glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II [J].
Yamaguchi, H ;
Ishiguro, K ;
Uchida, T ;
Takashima, A ;
Lemere, CA ;
Imahori, K .
ACTA NEUROPATHOLOGICA, 1996, 92 (03) :232-241
[48]   Presenilin 1 interaction in the brain with a novel member of the Armadillo family [J].
Zhou, JH ;
Liyanage, U ;
Medina, M ;
Ho, C ;
Simmons, AD ;
Lovett, M ;
Kosik, KS .
NEUROREPORT, 1997, 8 (06) :1489-1494